ArticleRheumatology and therapy2026

Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study.

Jieruo Gu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.